Last reviewed · How we verify

Zurampic — Competitive Intelligence Brief

Zurampic (LESINURAD) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Urate Transporter 1 Inhibitor. Area: Hematology.

marketed Urate Transporter 1 Inhibitor Solute carrier family 22 member 11 Hematology Small molecule Live · refreshed every 30 min

Target snapshot

Zurampic (LESINURAD) — Ironwood Pharms Inc.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Zurampic TARGET LESINURAD Ironwood Pharms Inc marketed Urate Transporter 1 Inhibitor Solute carrier family 22 member 11 2015-01-01

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Urate Transporter 1 Inhibitor class)

  1. Ironwood Pharms Inc · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Zurampic — Competitive Intelligence Brief. https://druglandscape.com/ci/lesinurad. Accessed 2026-05-14.

Build your own brief

Pick any drug + add comparators: